acquisition
-
Health IT, Telemedicine, Physicians
Staffing firm AMN Healthcare buys telehealth provider for $42.5M
AMN Healthcare bought Synzi, a virtual care provider, to offer customers greater staffing flexibility. The acquisition is a part of the company’s strategy to keep pace with the evolving market, where a greater emphasis is being placed on virtual care delivery and remote patient monitoring.
-
Humana purchases remaining 60% stake in Kindred at Home for $5.7B
After initially purchasing a 40% stake in Kindred at Home for $2.4 billion in 2018, Humana is now fully acquiring the home health and hospice provider for an additional $5.7 billion. The provider will transition to Humana’s payer-agnostic healthcare services brand CenterWell.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Appriss Health to buy PatientPing, expanding care coordination capabilities
Appriss Health, which provides behavioral health insights to clinicians, plans to purchase care coordination solutions provider PatientPing for an undisclosed sum. The deal is expected to close within the next two months, but the combined company’s first steps are still being decided.
-
Hospitals to DOJ: UnitedHealth’s purchase of Change Healthcare will curtail competition
The American Hospital Association is urging the Justice Department to thoroughly review UnitedHealth’s intended acquisition of Change Healthcare. The transaction would reduce competition in the health IT arena and result in higher prices and lower quality of care, the hospital group says.
-
Cigna to purchase long-standing partner MDLive
The insurer is buying the telehealth company for an undisclosed sum through its health services portfolio Evernorth. The acquisition will enable Evernorth to offer a 24/7 virtual care platform to health plans and employers, including non-Cigna members.
-
Centene to bolster behavioral health services with $2.2B Magellan Health acquisition
The insurer will pay $95 per share in cash to acquire Magellan Health, a company providing an array of services, including pharmacy benefit management and behavioral health and employee assistance program services. The companies aim to develop a behavioral health platform.
-
EverCommerce buys healthcare communication platform Updox
EverCommerce, a provider of solutions for businesses in the service sector, has added Updox to its roster of health services companies. Updox offers a variety of virtual care, patient engagement and office productivity solutions.
-
Cerner to snap up Kantar’s health division for $375M
The EHR giant is planning to buy Kantar Health, which provides data, analytics and research to the life sciences industry. Through the acquisition, Cerner aims to provide its clients with more access to data analytics and research expertise and engagement with life sciences companies.
-
Health IT, Hospitals, Health Tech
Private equity firm acquires care coordination platform Central Logic
Private equity firm Rubicon Technology Partners acquired a majority stake in Central Logic for an undisclosed amount. Central Logic developed software solutions to help manage the transfer of high-acuity patients between hospitals.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Teladoc to acquire InTouch Health for $600M
Teladoc reached an agreement to acquire InTouch Health for $600 million, including $150 million in cash. The deal is expected to add roughly $80 million to Teladoc’s top line.
-
Artificial Intelligence, Health IT, Hospitals, SYN
OR software company raises $45.6M and makes a new acquisition
Boston-based Caresyntax raised $45.6 million and acquired Syus, an analytics provider for hospitals.
-
Novartis to acquire The Medicines Co., maker of cholesterol-lowering drug, for $9.7B
The deal will give the Swiss drugmaker control of inclisiran, a drug for which The Medicines Company plans to file for approval in lipid disorders starting this quarter.
-
BMS to sell $1.6B psoriasis drug to satisfy FTC concerns about Celgene acquisition
The drugmaker said Monday it would sell off the drug Otezla to address concerns about competition that the Federal Trade Commission had expressed in connection to the pending $74 billion deal. According to an analyst, BMS saw Otezla as competitive against its investigational TYK2 inhibitor.
-
McKesson UK acquires British medication management startup Echo
Through its app, London-based Echo, which was founded in 2015, offers prescription fulfillment and reminders to take medications.
-
Accumen buys clinical data exchange company Halfpenny Technologies
Accumen, which assists organizations with outreach services, imaging, clinical laboratory operations and patient blood management, has scooped up Pennsylvania-based Halfpenny for an undisclosed amount.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
